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Objectives . The goal of this study was to investigate the
evolution of endothelial dysfunction told plasma resin activity in a
rat model of heart failure.
Background . Endothelial dysfunction has been demonstrated
in heart failure and may play a significant role in this pathophys-
iologic process. Studies have also, suggested a physiologic interac-
tion between the resin-angloteesin system and endothelium-
derived relaxing factor. However, the evolution of endothelial
dysfunction and plasma resin activity in heart failure has net been
studied to date.
Methods. Endothelium-dependent and -independent relax-
ations were studied at 1, 4 and 16 weeks after coronary artery
ligation In a rat model of heart failure . Thoracic aortic rings were
placed In Isolated organ baths and acetytholine and sodium
nitroprnsside concentration response curves were generated .
Plasma resin activity was assessed at each time point .
Decreased endothelium-dependent relaxation of the systemic
vasculature in response to acetylcholine has been demon-
strated in patients with severe heart failure (1-3). However, the
confounding effects of other diseases known to affect endothe-
lium-dependent relaxation could not be entirely controlled in
these investigations. In the canine pacing model of heart
failure, studies have shown conflicting results (4,5), whereas in
the rat coronary artery ligation model, significantly decreased
endothelium-dependent relaxation in the pulmonary (6) and
systemic (7,8) vasculature has been demonstrated. The evolu-
tion of these changes in the systemic vasculature over time has
not been evaluated to date .
The importance of time in the pathogenesis of heart
failure has been established in many studies, especially those
investigating ventricular enlargement (9), and has affected
current approaches to the treatment and prevention of
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Results. Aortic rings from rats with heart failure demonstrated
no evidence of endothellal dysfunction at week 1, although pro .
gressive rightward shifts hi the acetylchollne curves and decreas-
ing maximal relaxation over time compared with findings in
sham-operated control rats were evident at weeks 4 and 16 . The
sodium nitroprusside curves were not different between rats with
heart failure and sham-operated rats . Plasma resin activity was
elevated at week I and progressively increased through week 16,
even though it correlated poorly with endothelial dysfunction .
Conclusions. This study suggests that endothelial dysfunction
in heart failure is a progressive tilne.dependent proem that
probably plays a minor role early In heart failure. Although
plasma resin activity Increased significantly in rats with heart
fatinre, It was poorly predictive of endothelial dysfunction .
(J Am Coll Cardiol 1993;22:61520)
congestive heart failure (10) . Endothelial dysfunction may
represent another pathophysiologic state that evolves over
time and may ccrtribute to the maintenance and progression
of heart failure . An analysis of the temporal evolution of
endothelial dysfunction in patients would be extremely dif-
ficult to perform and consequently we used the coronary
artery ligation model to investigate the evolution of endo-
thelial dysfunction in the thoracic aorta of rats with heart
failure . In addition, a secondary goal of our study was to
assess the evolution of plasma renin activity, a marker of
renin-angiotensin system stimulation, and its possible rela-
tion to endothelial dysfunction .
Methods
Myocardial infarction and selection procedure . Thirteen-
week old male Wistar rats were randomly selected to un-
dergo coronary artery ligation or sham operation by a
technique previously described (11,12) . In brief, the rats
were anesthetized with ether and a left thoracotomy was
performed. Through gentle pressure applied
to the right
hemithorax, the heart was .xteriorized and a ligature was
placed around the proximal left coronary artery . This silk
suture was tied securely in the rats randomized to coronary
artery ligation, but was pulled through in ' .he sh
;+m-operated
animals
. The heart was rapidly replaced into the chest and
0735
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the thorax was closed
. Within the 1st 48 h after this proce-
dure, 60% of the ligated and 99% of the sham-operated
animals survived . The rats were housed in clear plastic cages
with free access to normal rat chow and water and were
handled according to the "Position of the American Heart
Association on Research Animal Use adopted November
It, 1984 by the American Heart Association .
At least 3 days after the coronary ligation or sham
procedure and 3 days before isolated organ bath studies, the
rats underwent catheterization. Under ether anesthesia,
a
micratipped pressure transducing catheter 2F, model SPC
320, Millar Instruments was introduced into the thoracic
aorta through the right carotid artery where arterial blood
pressure and heart rate tracings were obtained . The catheter
was advanced into the left ventricle and simultaneous trac-
ings of left ventricular pressure, expanded-scale left ventric-
ular end-diastolic pressure, maximal rate of rise in left
ventricular pressure dP/dt and heart rate were also re-
corded on a linear chart recorder Linearcorder Mark VII,
model WR3101, Graphtec Corp . . Sham-operated rats were
randomly selected to enter the study, whereas only rats that
underwent ligation with a left ventricular end-diastolic pres-
sure z15 mm Hg were considered to have congestive heart
failure and completed the study protocol .
Organ bath studies. At 1, 4 and 16 weeks after myocar-
dial infarction, the rats were anesthetized with ether, 8 ml of
blood was withdrawn for biochemical analysis and the
thoracic aorta and heart were immediately excised . The
heart was placed in Krebs-Henseleit solution until prepara-
tion for pathologic studies could be performed . The thoracic
aorta was dissected and cut into two 5-mm rings, the first of
which was left intact, whereas the second was denuded of
endothelium by gentle rubbing of the intimal surface. In each
experiment, an aortic segment from a sham-operated control
rat was studied in parallel with that from a rat with heart
failure. Each ring was suspended in a 10-ml isolated organ
bath filled with Krebs-Henseleit solution in mmollliter: sodium
chloride 115, potassium chloride 4.7, magnesium sulfate 1 .2,
potassium biphosphate 1 .5, sodium bicarbonate 25, calcium
chloride 2.5, glucose 11 .1 kept at 37°C and gassed with a
mixture of 95% oxygen/5% carbon dioxide . The rings were
connected to force transducers and isometric tension was
recorded Linearcorder Mark VII, Graphtec Corp. .
The rings were stretched to a tension of 3 g at rest and,
^~Ter an equilibration period, all rings were contracted with
10° mollliter norepinephrine . Subsequently, l0- mollliter
of acetylcholine was administered to check for the presence
of functioning endothelium on rings with intact endothelium
and for the absence of endothelium an the rings that
were rubbed . After the rings had been washed and returned
to a stable baseline state, norepinephrine 3 x 10-8 to I x
10-7 mollliter was administered to the rings in a concentra-
tion so as to obtain a stable contraction and to approximate
the developed tension of the matching control ring. In
rings with intact endothelium, acetylcholine concentration-
response curves were then generated by adding cumulative
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doses of acetylcholine 10-9 to 10-4 mollliter . The concen-
tration of acetylcholine inducing 50% maximal relaxation
and the maximal relaxation were measured. On rings where
the endothelium had been mechanically removed, cumula-
tive concentrations of sodium nitroprusside from 10 10 to
10-5 mollliter were given and the concentration inducing
50% of the maximal relaxation and the maximal relaxation
were measured .
Biochemical and pathologic studies . At the time of in-
duced death, the blood was withdrawn into a syringe con-
taining 50 µliter of 5% ethylenediamenetetraacetic acid per
ml of blood . These blood samples were immediately centri-
fuged for 5 min at 13,000 rpm. Subsequently, the plasma was
placed in dry ice and then stored at -20°C until time of
assay. Plasma renin activity was assessed by a standard
technique at pH 7 .4 13 . using a commercial radioimmuno-
assay kit Baxter Healthcare Corp . to quantify the amount
of angiotensin I generated from angiotensinogen . The great
vessels and adherent tissues were trimmed from the heart
and the right ventricular free wall was dissected away from
the left ventricle . Ventricular weights were obtained to provide
a rough estimate of ventricular mass and then the ventricles
were immediately placed in a 10% formalin solution . The size
of the infarct was estimated by a method previously described
14 , where 10 10-µm thin slices of the left ventricle were
stained with Masson trichrome . The endocardial and epicardial
circumferences of the infarcted portion and the total left
ventricle were determined with a planimeter digital image
analyzer Sony and values were averaged to yield a percent of
ventricular infarction for each rat .
Study design and statistical analysis. The overall design of
this investigation consisted of studying the two groups of rats at
three time periods I, 4 and 16 weeks after myocardial
infarction. All statistical comparisons were performed with
commercially available general linear model statistical pack-
ages for the Macintosh personal computer SuperANOVA,
Version 1.11 ; Statview, Version 4.0; Abacus Concepts, Inc . .
Comparison of all variables was done with a two-way analysis
of variance with time 1, 4 and 16 weeks and group as main
effects, and three prospectively planned means comparison
contrasts between rats with heart failure and sham-operated
rats at each time point . One-way analysis of variance with
Duncan s multiple comparison tests was used to analyze dif-
ferences within a group across time . Stepwise multivariate
linear regression and simple linear regression were also per-
formed to investigate the relation between different variables .
Differences were considered significant at a level of p < 0 .05
and results are expressed as mean value ± SEM .
Results
Hemodynamic and baseline characteristics Table 1 . At
least 10 rats in each study group completed the protocol.
Rats with heart failure weighed less than the time-matched
control rats at each period p < 0.01 for all comparisons ,
though both groups gained weight at a similar rate . The mean
JACC Vol. 22, No . 2
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Table 1 . Physical Characteristics, Hemodynamic Variables and Plasma Renin Activity Over Time
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Results are expressed as mean value ± SI?M . CHF = rats with congestive heart failure ; dPldt = maximal rate of rise in left ventricular pressure ; HR = heart
rate ; LV = left ventricular ; LVEDP = left ventricular end-diastolic pressure ; LVSP = left ventricular systolic pressure ; MAP - mean arterial pressure; PRA =
plasma renin activity ; RV = right ventricular ; Shane = sham-operated rats .
arterial blood pressure, left ventricular systolic pressure and
heart rate were significantly lower in rats with heart failure
than in control rats, but did not change significantly with
time. The maximal rate of rise in the left ventricular pressure
dPidt was also lower in rats with heart failure than in
sham-operated rats, though it decreased with age in a similar
fashion in both groups of rats. The left ventricular end-
diastolic pressure was markedly elevated in the rats with
heart failure, as would be expected given the selection
criteria . The left ventricular mass indexed for body weight
remained stable in the sham-operated rats overall mean
1 .84 ± 0.02 glkg , but increased through time in the rats with
heart failure week I vs . week 16, p < 0.001 . Each of these
values was higher in the rats with heart failure than in the
time-matched control rats p < 0.001 . A similar pattern was
evident in the right ventricular mass indexed for body
weight, with values in sham rats stable through time overall
mean 0.50 ± 0.01 glkg as the values in rats with heart failure
progressively increased week 1 vs. week 16 p < 0.001 .
However, myocardial infarct size was not significantly dif-
ferent in the rats with heart failure 42 ± 1% between time
periods and there was no evidence of infarction in any of the
sham-operated rats .
AcetyMholine concentration-response curves . Acetylcho-
line concentration-response curves were obtained in aortic
rings with endothelium after precontraction with nor-
epinephrine . In aortic rings from the control rats, the ace-
tylcholine concentration-response curves were not signifi-
cantly different with respect to time ; thus, these data were
pooled and 95% confidence intervals were calculated to
produce the shaded area shown in Figure 1 . In vessels from
the rats with heart failure, concentration-response curves
shifted progressively to the right through time Fig. I
. The
concentration of acetylcholine that produced 50% of maxi-
mal relaxation Fig. 2 was not significantly different be-
tween aortic rings from rats with heart failure and sham-
operated rats at week 1, but was markedly higher in the
vessels from rats with heart failure at weeks 4 and 16 p <
0.001 . The 16-week heart failure group had a significantly
higher concentration of acetylcholine that produced 50% of
maximal relaxation than that of the sham group p = 0.0001
or of rats with heart failure at I and 4 weeks p < 0.05 . The
maximal relaxation, expressed as a percent of the initial
contraction, also decreased over time in the rats with heart
failure compared with the value in sham-operated rats p
0.0012 . At week 16, the maximal relaxation of 89 ± 5% in
the rings from rats with heart failure was markedly less than
that found in the corresponding sham-operated rats 95 ±
2%; p = 0.0001 . There was a small though significantly
higher starting tension in the rings from rats with heart
Figure 1. Acetylcholine concentration-response curves in aortic
rings with endothelium from rats with heart failure . Theshaded area
represents the 95% confidence range for
the sham-operated control
rats. Notice the progressive rightward shift over time in the rats with
heart failure and the significant decrease in maximal relaxation in the
rats with heart failure at 16 weeks . log = logarithmic
; M = molliter ;
NE = norepinephrine; t = p < 0.01 for rats with
heart failure at that
time period versus control rats .
0
0
Y
V
20
0
z ao
F,
0
60
so-
--w- Week I n=18
--o- Week 4 n=24
-a- Week 16 n=10
~; t
0
100 ~ -~,---r--
p4 Baseline -9 -8 -7
-6 -5 .4
Acetylcholine Concentration log M
Week I
Sham 21 362±4 1 .880.03 0.51±0.02 384±7 121±2 137±2 0.9±0.2 15 .5± . • . 6 11.2±0.9
CHF 18 321±7 2.00±_0 .05 0.84±0.05 362±6 88±2 101±2 19.1±0.8 6.9± v .3 22.0 1 .3
Week 4
Sham 23 375 ± 7 1 .83 ± 0.02 0 .50 ± 0.02 375 ± 8 118 ± 2 135 ± 2 0.7 ± 0 .3 13 .4 ± A.6 6 .3 t 0 .5
CHF 24 352 ± 4 2 .14 ± 0 .04 1 .10 ± 0.05 356 ± 5 93 ± 2 103 ± 2 23 .1 ± 1 .1 6 .0 ± 3.2 20 .1 t 1 .1
Week 16
Sham 10 426±7 1.82±0.03 0.48±0.02 370± 11 120±3 135±3 1 .4±0.5 12.8±0.6 3.7±0 .3
CHF 10 402±9 2.30±0.09 1.24±0.12 363±8 95±4 106±3 22.7±2.0 5.8±c- .5 12.2±1 .3
Interaction effect p value 0.2254 0.0012 0.0001 0.6342 0 .1127 0 .3863 0 .0565 0 .2793 0 .0500
Time effect p value 0.0001 0.0587 0 .0091 0.5031 0 .4562 0 .7199 0 .0544 0.0005 0 .0001
Group effect p value 0.0001 0.0001 0 .0001 0.0104 0 .0001
0 .0001 0 .0001 0.0001 0 .0001
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Weight LV Mass RV Mass HR MAP LVSP LVEDP LV td. .at PRA
Time No . g €!kg gkg beats min mm Hg mm Hgl cam Hg Ix 103 mm . gis Ipg Al/ml per h
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• Week 1
• Week 4
® Week 16
Sham CHF
Flgmre 2. Acetylcholine K se
of concentration-response curves in
sortie flags with endothelium in sham-operated control rats Sham
and rats with heart failure CHF . There were no differences
between the sham-operated rats with time, and differences among
the rats with heart failure are indicated . The within-time group
comparisons of sham-operated rats and rats with heart failure were
significant Tier week 4 p - 0.0209 and week 16
p s 0.0001 ,
demonstrating progressive endothelial dysfunction through time .
nM = nanomot/liter.
failure overall mean in sham-operated rats 0.87 ± 0.04 g vs .
overall mean in rats with heart failure 1 .17 ± 0.04 g, p <
0.01 , but there were no significant differences within the
heart failure or sham groups with respect to time . Thus, any
changes in these curves with respect to time were not due to
different initial contractions .
Sodium uifropraudile concentration respmsse caimes . Aortic
rings without endothelium from rats with heart failure and
sham-operated rats were exposed to cumulative concentrations
of sodium nitroprusside after precontraction with norepineph-
rine to investigate endothelium-independent relaxation . The
concentration-response curves for the rats with heart failure
F%m 3. Sodium nitroprusside concentr°ttlon-response curves in
aortic rings without endothelium from sham-operated control rats
Sham and rats with heart failure CHF . Curves represent data
pooled from all time periods because there were no differences in the
responses to sodium nitroprusside at any time or concentration within
groups. There were also no differences in sodium nitroprusside-
induced 500 maximal relaxation or maximal relaxation between the
groups. Abbreviations as in Figure 1 .
a - Sham n=48
-- -- CHF n=47
--
a
too
e1 9 8
	 e
Basline -0
-7
-6 -5
Sodium Nitroprusside log M
0
Week 1
® Week 4
E]
Week
16
Sham CHF
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Figure 4. Plasma renin activity in sham-operated control rats
Sham and rats with heart failure ClIF . The within-time group
comparisons of sham-operated control rats and rats with heart
failure were significant for each time period tp < 0 .01 .
were not different from the control curves Fig. 3 . nor was the
sodium ntroprusside concentration that produced 5010 of
maximal relaxation or maximal relaxation response different
between the two rat groups . The starting tension in the sham
rings did not change through time overall mean 2 .74 ± 0.06 g .
The initial -rontractions in vessels from tats with heart failure at
weeks I and 4 were significantly less than the corresponding
control contractions week 1. 2.18 ± 0 .10 g; week 4, 2 .19
0.11 g ; p < 0.05 , though at week 16 there was no difference
between the heart failure and sham rings week 16, 2.88 ±
0.20 g .
Plasma resin activity in chronic heart failure . Plasma
resin activity was significantly increased at every time point
in the heart failure group p < 0.0001 . Absolute values of
plasma renin activity changed significantly with time in both
the control and heart failure groups Table 1 . However,
when the plasma resin activity was expressed as a percent of
time- and assay-matched control values Fig . 4 , plasma
renin activity clearly increased through time in the rats with
heart failure . Multiple stepwise linear regression analysis
was used to determine which of the hemodynamic and vascular
responsiveness variables were most closely associated with the
plasma resin activity in rats with heart failure and three
variables wen., moderately correlated with plasma renin activ-
ity, namely, left ventricular and right ventricular mass and the
acetylcholine concentration that produced 50% of maximal
relaxation Plasma resin activity = 212 Left ventricular mass
142 Right ventricular mass - 0.265 Acetylcholine concentra-
tion that produced 50% of maximal relation - 272; r = 0.607,
ra = 0.368 . To address the question of whether plasma resin
activity could be predictive of the endothelial dysfunction,
linear regression was performed with plasma renin activity as
the dependent variable versus either the acetylcholine concen-
tration that produced 50% of maximal relaxation or maximal
acetylcholine-induced relaxation. Plasma renin activity was
poorly predictive of the acetylcholine concentration that pro-
JACC Vol . 22, No . 2
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duced 50% of maximal relaxation r = 0 .31 %
	
0.0043 and
was not predictive of maximal relaxation.
Discussion
The present study using the coronary artery ligation rat
model shows that endothelial dysfunction is a delayed phe-
nomenon that evolves over time . Despite marked hemo-
dynamic abnormalities present at week 1, endothelial dys-
function in response to acetylcholine emerged only after 4
weeks of heart failure and progressed through week 16 . This
worsening dysfunction occurred in the presence of a pre-
served vascular smooth muscle response to sodium nitro-
prusside, confirming the finding that this dysfunction is
endothelium dependent . Plasma renin activity was increased
in the rats with heart failure at week I and continued to be
elevated above control values through week 16, though it
was a poor predictor of the endothelial dysfunction .
Coronary artery ligation in the rat has been one of the most
useful models in elucidating the pathophysiology of heart
failure and was instrumental in evaluating the effectiveness of
angiotensin-converting enzyme inhibitors in prolonging sur-
vival 15,16 . The presence of heart failure as demonstrated by
the increased left ventricular end-diastolic pressure was asso-
ciated with increases in left and right ventricular mass, which
corresponds to findings of previous studies 11 . The absence
of any confounding diseases in this model, such as atheroscle-
rosis 17 , hypercholesterolemia 18 , hypertension 19 , insu-
lin-dependent diabetes mellitus 20 or other diseases known to
effect endothelium-dependent relaxation, provides an opportu-
nity to investigate independently the evolution of endothelial
dysfunction in heart failure .
Role of progressive endothelial dysfunction in heart failure .
In this study, decreased endothelium-dependant relaxation
in the systemic circulation was evident only at 4 weeks after
myocardial infarction and progressively worsened through
week 16, Another study 21 of the time course of the
hemodynamic changes in rats with similar infarct sizes
demonstrated that the systemic vascular resistance followed
the same pattern, with nonsignificant increases evident at 10
weeks and marked increases present 20 weeks after infarc-
tion. The findings from our study suggest that progressive
endothelial dysfunction over time could contribute to the
inexorable hemodynamic deterioration evident in severe
heart failure. Furthermore, because the hemodynamic com-
promise was present at week 1 at a time when endothelial
dysfunction was absent, our findings suggest that endothelial
dysfunction in heart failure is not merely the direct result of
hemodynamic insufficiency .
Since the discovery of endothelium-derived relaxing fac-
tors 22 , one of which s now considered to be nitric oxide
23 , and other endothelium-derived factors, the endo-
thelium has been recognized as a dynamic regulator of
vascular tone . In the coronary artery iigation rat model of
heart failure, decreased relaxation in rrspouse to acetylcho-
line has also been shown in isolated aor1c 8 and pulmonary
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6 artery ring segments and in the isolated hindquarter 7 of
rats with 10 to 12 weeks of heart failure . Other studies in the
ventricular overdrive pacing canine model of heart failure
have found both decreased 4 and normal 5 endothelium-
dependent vasorelaxatiun . Similarly, the basal release of
nitric oxide has been reported to be normal in the coronary
artery ligation rat model 7,24 but significantly decreased in
the dog model 25 of heart failure . Studies in humans with
severe heart failure have consistently demonstrated abnor-
malities in endothelium-mediated relaxation as assessed by
changes in the coronary blood flow 1 , forearm blood flow
2 and superficial femoral artery blood flow velocity 3 .
Thus, endothelial dysfunction as demonstrated by decreased
relaxation to acetylcholine appears to be present in estab-
lished severe heart failure . However, our study is the first to
demonstrate the time course of these pathophysiologically
important changes in the .oronary artery ii : tion rat model
of heart failure, where effects of concomitant diseases can be
eliminated .
The acetylcholine-induced release of nitric oxide causes
vasodilation through a soluble guanylate cyclase in the smooth
muscle cell that can also be stimulated independently of the
endothelium by organic nitrates, such as sodium nitroprusside
26 . In our study, endothelium-independent relaxation was
intact from week I to 16, as has been shown in other studies at
10 to 12 weeks after coronary artery ligation 7,8 . Studies 2 in
humans with heart failure have likewise demonstrated no
difference in vasodilator response to nitroprusside, though one
study suggested that there was decreased responsiveness to
nitroglycerin in patients with heart failure 3 . These findings
suggest that the decreased relaxation response to acetylcholine
is not due to diminished vascular smooth muscle responsive-
ness. Other possible mechanisms include alterations in acetyl-
choline receptor number of affinity, dysfunction of the nitric
oxide synthase pathway and abnormal diffusion of the relax-
ation factor in heart failure .
Plasma resin activity and endothelial dysfunction . Neuro-
humoral activation plays a prominent role in the pathophys-
iology of heart failure ; in studies 27,28 of patients with
heart failure, plasma renin activity was significantly in-
creased and was shown to correlate with mortality by
univariate analysis . In the ventricular overdrive pacing dog
model of heart failure 29 , increased plasma renin was
noted, though studies in the rat coronary artery ligation
model have found both no increase 30-32 and variable
increases 33-35 in plasma renin activity . In
our study, the
plasma renin activity of rats with heart failure was clearly
elevated at week I and progressively increased through
week 16. Unlike the studies that found no increase in renin,
this study had specific selection criteria to establish the
presence of heart failure left ventricular end-diastolic pres-
sure ~ 15 mm Hg , which may account for our results
.
Endothelial dysfunction may play an important role in the
pathogenesis of heart failure, though no noninvasive
markers for this abnormality have been discovered . In the
rat coronary artery ligation model, administration of an
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angiotensin-converting enzyme
inhibitor, captopril, pre-
vented the development of endothelial dysfunction in the
pulmonary artery 36 , suggesting a possible relation be-
tween stimulation of the renin-angiotensin system and endo-
thelial dysfunction in heart failure . A physiologic relation
between endothelium-derived relaxing factor and renin re-
lease has also been suggested 37-39 . However, in our
study, plasma resin activity was poorly predictive of endo-
thelial dysfunction and thus is not a useful noninvasive
marker for endothelial dysfunction in heart failure .
Concluslels . The present study shows that systemic en-
dothelial dysfunction is a delayed phenomenon that evolves
over time in heart failure . Ventricular remodeling is also n
slowly evolving process that has been shown to be prevented
by chronic angiotensin•converting enzmn a inhibition. Thus,
further studies are needed to determine if therapeutic inter-
vention can prevent the systemic endothelial dysfunction
evident in heart failure .
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